Quest Diagnostics and the University of California, San Francisco (UCSF) have formed a collaboration to accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine. Initial clinical areas of focus include autism, oncology, neurology, and women’s health. The collaboration combines the research discoveries and capabilities of UCSF with the national testing database and technical and clinical development capability of Quest Diagnostics.
Under the terms of the agreement, scientists will jointly research, develop, and validate diagnostic innovations to solve specific clinical problems and provide actionable information to improve patient care. The organizations will focus on diagnostics to advance precision medicine, an emerging field of medical science that aims to integrate the most informative data from molecular, clinical, population and other research to create predictive, preventive, and precise medical solutions. Quest Diagnostics will independently develop and validate any lab-developed tests for clinical use that emerge from the collaboration’s research.
Researchers will utilize laboratory-based diagnostics, imaging procedures and population analysis based on Quest’s national Health Trends database, based on more than 1.5 billion patient encounters, to advance precision medicine. The alliance is the first master agreement that UCSF’s Office of Innovation, Technology and Alliances has signed with a clinical laboratory testing company and augments the university’s efforts to translate laboratory research into new therapies. The broad agreement lays the groundwork for multiple projects between the two organizations. Learn more about Quest Diagnostics and UCSF.
